WHO ICTRP trial

Evaluation of efficacy of "Ziziphus Vulgaris" formula to prevent “drug induced…

IRCT20181107041586N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting

Key facts

Trial ID IRCT20181107041586N1
Public title Evaluation of efficacy of "Ziziphus Vulgaris" formula to prevent “drug induced liver enzyme disorder” in pulmonary tuberculosis Patients
Scientific title Evaluation of efficacy of “Ziziphus Vulgaris” formula to prevent “drug induced liver enzyme disorder” in pulmonary tuberculosis Patients
Primary sponsor Sari University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Recruiting
Study type interventional
Phase 3
Countries Iran (Islamic Republic of)
Conditions drug-induced hepatotoxicity. Toxic liver disease, unspecified;K71.9
Interventions Intervention 1: Intervention group: Patients are treated with jujube-based syrup for a month receiving 10 cc of the syrup two times a day, fasting morning and half an hour before bedtime. Routine anti-TB treatment will be implemented in…
Registration date Aug 10, 2019
Target size 70
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations